Stay Informed on Corporate Sustainability

Author: Bianca Odron

Ahead of the Life Sciences Industry Conference 2026, Dinny Crowe of ABM shares his perspective on why 2026 is a pivotal year for AI adoption in life sciences manufacturing and what regulated organisations need to get right.

Author: Bianca Odron

Ireland’s review of Mounjaro highlights how pharmaceutical pricing negotiations and clinical evidence are shaping access to innovative metabolic treatments, with implications for reimbursement strategy and future drug development.

Author: Bianca Odron

FedEx’s new European booking portal gives Irish pharmaceutical and biotech businesses simpler access to temperature-controlled shipping, supporting critical medicine logistics, shipment visibility and reusable packaging.

Author: Bianca Odron

Northern Ireland’s new health innovation partnership aims to connect life sciences research with clinical needs, accelerate adoption of proven solutions and create opportunities for investment and economic growth.

Author: Bianca Odron

ALS Identify has been announced as a Bronze Collaboration Partner for the Life Sciences Industry Conference 2026, bringing specialist expertise in identification, traceability, and labelling solutions to Ireland’s life sciences sector. Supporting more than 40 life sciences companies across Ireland, ALS Identify provides technology and local expertise spanning labelling, printing, barcode, scanning, automation, and traceability solutions for regulated environments.

Author: Bianca Odron

The official highlights video from the Pharma Industry Awards UK 2026 is now available, celebrating outstanding achievement across the UK's pharmaceutical and life sciences sector at the Park Plaza London Riverbank on 23rd September.

Author: Bianca Odron

The Life Sciences Industry Conference 2026 has completed its speaker line-up, bringing together senior leaders across pharmaceutical manufacturing, digital transformation, regulatory science and AI.

Author: Bianca Odron

Ireland’s growing convergence of pharma, medtech, AI and digital health is creating new opportunities for pharmaceutical companies to develop, test and scale connected solutions within an increasingly integrated life sciences ecosystem.

Author: Bianca Odron

Oxford Science Enterprises has appointed biotech investor Jeffrey Moore to lead its Life Sciences team, strengthening the commercialisation of academic research and UK pharmaceutical innovation.

Author: Bianca Odron

UCD’s new Infection Research Ireland brings together infectious-disease research, clinical trials and industry collaboration, strengthening Ireland’s pharmaceutical research infrastructure and capacity for future health challenges.